Northwest & Ethical Investments’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-44,555
| Closed | -$2.49M | – | 503 |
|
2023
Q4 | $2.49M | Hold |
44,555
| – | – | 0.08% | 227 |
|
2023
Q3 | $1.84M | Sell |
44,555
-1,163
| -3% | -$48K | 0.06% | 236 |
|
2023
Q2 | $2.55M | Buy |
45,718
+1,862
| +4% | +$104K | 0.08% | 230 |
|
2023
Q1 | $2.45M | Hold |
43,856
| – | – | 0.08% | 231 |
|
2022
Q4 | $1.6M | Buy |
43,856
+5,455
| +14% | +$199K | 0.06% | 265 |
|
2022
Q3 | $1.09M | Hold |
38,401
| – | – | 0.04% | 282 |
|
2022
Q2 | $1.74M | Buy |
38,401
+9,937
| +35% | +$450K | 0.07% | 253 |
|
2022
Q1 | $2.17M | Buy |
28,464
+19,539
| +219% | +$1.49M | 0.07% | 244 |
|
2021
Q4 | $1.33M | Buy |
+8,925
| New | +$1.33M | 0.04% | 275 |
|